AzTrials
AzTrials

Peripheral NeuropathyHYPTECNCT05623449

Teleconsultations Hypnosis Sessions for Patients With Peripheral Chronic Neuropathic Pain

A study testing Clinical examination, Anxiety and Depression Scale (HAD) and pain scale in people with Peripheral Neuropathy and Pain, run by University Hospital, Bordeaux at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this study is to assess the feasibility of hypnosis sessions performed in teleconsultations and led by a nurse, for patients with peripheral chronic neuropathic pain. Acceptability, satisfaction and effects (on pain and psychological distress) are also evaluated, comparing patients who have benefited from… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Peripheral Neuropathy, Pain
What is being tested?
Clinical examination, Anxiety and Depression Scale (HAD) and pain scale
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteFrance
Study dates
23 Feb 2023to 30 Apr 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patient aged over 18 years old,
  • Patient suffering of from peripheral neuropathic pain for more than 1 year,
  • Patient referred for hypnosis management as part of a coordinated care support,
  • Patient who accepts teleconsultation, having the appropriate equipment to attend teleconsultations (computer, microphone, camera and stable internet connection with sufficient internet speed) and the ability to use it independently,
  • Patient having signed a free, informed and written consent,
  • Patient affiliated or beneficiary of the social security system.

Who cannot join

  • Patient with severe and unstable neurocognitive or psychiatric conditions (depression, psychoses, major cognitive impairments),
  • Patient with uncorrected deafness,
  • Patient with poor understanding of French
  • Patient placed under judicial safeguard, guardianship or curatorship.

Trial locations and contacts

1 site in 1 country.

France1 site
  • Université Hospital, Bordeaux

    Pessac, Pessac, 33600

Other trials in France

About this study

Official title: Monocentric Pilot Study of the Feasibility of Teleconsultations Hypnosis Sessions Led by a Nurse for Patients With Peripheral Chronic Neuropathic Pain - HYPTEC

The aim of this study is to assess the feasibility of hypnosis sessions performed in teleconsultations and led by a nurse, for patients with peripheral chronic neuropathic pain. Acceptability, satisfaction and effects (on pain and psychological distress) are also evaluated, comparing patients who have benefited from teleconsultations and those who did not.

Read the detailed description

Factors explaining peripheral chronic neuropathic pains are complex ; they require a personalized therapeutic strategy and multidisciplinary management. Among the recommended management, psychocorporal approaches such as hypnosis, are subject of recent interest. At the CHU de Bordeaux, the management of patients suffering from such chronic pains, consists of 5 hypnosis sessions, conducted face-to-face, each performed one month apart : the first session is carried out by a doctor and a hypnotherapist nurse and the 4 following sessions by the hypnotherapist nurse alone. However, it seems that this usual management is not easily accessible for patients who are geographically distant and/or who are unable to move due to excessive pain. In such situations, teleconsultations would avoid travel for these patients with low mobility and then would an interesting alternative to face-to-face consultations. Few studies have been done on hypnosis sessions led by teleconsultations. So, the whole purpose of this study is to compare the management of 15 patients by teleconsultations (experimental arm) with 15 other patients seen in face-to-face (control arm) to evaluate feasibility of teleconsultation in hypnosis.

Being tested
Clinical examination, Anxiety and Depression Scale (HAD), pain scale, hypnosis consultation, Maintenance
Keywords
peripheral chronic neuropathic pain, hypnosis, teleconsultations, feasability
Medical subject headings
Peripheral Nervous System Diseases, Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Clinical examinationOther

    Current medications (only those prescribed to treat pain, anxiety and depression), non-drug treatment(s) prior to treatment in hypnosis as well as any ongoing treatment(s).

  • Anxiety and Depression Scale (HAD)Other

    To screen for anxious and depressive symptoms

  • pain scaleProcedure or surgery

    Measurement of pain intensity

  • hypnosis consultationProcedure or surgery

    5 hypnosis consultation

  • MaintenanceProcedure or surgery

    Qualitative assessment

  • Data collectionOther

    Age, sex, socio-professional category, level of education, comorbidities, date of diagnosis of chronic peripheral neuropathic pain, distance between home and hospital.

Study groups in NCT05623449
Study groupRoleWhat they receive
combination of face-to-face and teleconsultation hypnosis consultationExperimentalThe first and the last hypnosis sessions in face-to-face, and the other 3 intermediate sessions being conducted by teleconsultation.
Receives: Other: Clinical examination; Other: Anxiety and Depression Scale (HAD); Procedure: pain scale; Procedure: hypnosis consultation; Procedure: Maintenance; Other: Data collection
face-to-face hypnosis consultationActive comparator5 face-to-face hypnosis sessions
Receives: Other: Clinical examination; Other: Anxiety and Depression Scale (HAD); Procedure: pain scale; Procedure: hypnosis consultation; Procedure: Maintenance; Other: Data collection

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. 5 hypnosis consultations (in face-to-face and by teleconsultation).

    The rate (%) of included patients who have completed the 5 hypnosis consultations (in face-to-face and by teleconsultation).

    Measured: Month 8

Secondary outcomes (5)
  1. Achievement/Acceptability

    Acceptance rate (%) of the proposal to participate in the study in the two study arms: face-to-face hypnosis care (control arm) and care including hypnosis teleconsultations (experimental arm).

    Measured: Month 8

  2. Numerical Pain Assessme

    Mean difference in pain score, minimum value is 0 and maximum value is 10

    Measured: Day 0, month 1, month 2, month 3 month 4 and montth 7

  3. Hospital Anxiety and Depression scale (HAD)

    Mean difference in the anxiety and depression score, minimum value is 0 and maximum value is 42

    Measured: Day 0, month 4 and month 7

  4. Learning self-hypnosis

    Evaluate the frequency of the use of self-hypnosis throughout the treatment.

    Measured: Day 0, month 1, month 2, month 3 month 4 and montth 7

  5. Ssatisfaction scale

    Evaluate the level of satisfaction and the feeling of the patients with regard to the nursing care in hypnosis at the end of the care in the two study arms (face-to-face control arm and experimental arm with teleconsultations).

    Measured: Month 7

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Nov 2022
  2. Study start23 Feb 2023
  3. Primary completion30 Apr 2024
  4. Study completion30 Apr 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
30 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05623449
Sponsor's protocol ID
CHUBX 2022/34
Other IDs
2022-A02022-41
Acronym
HYPTEC
Status last verified
Nov 2024
First submitted
27 Oct 2022
Last updated
2 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Clinical examination, Anxiety and Depression Scale (HAD) and pain scale in people with Peripheral Neuropathy and Pain, run by University Hospital, Bordeaux at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 2 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

5 hypnosis consultations (in face-to-face and by teleconsultation). (time frame: Month 8). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Jun 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in